nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A4—breast cancer	0.247	1	CbGaD
Dutasteride—CYP3A5—Lapatinib—breast cancer	0.0608	0.12	CbGbCtD
Dutasteride—CYP3A4—Exemestane—breast cancer	0.0469	0.0922	CbGbCtD
Dutasteride—CYP3A4—Letrozole—breast cancer	0.0399	0.0784	CbGbCtD
Dutasteride—CYP3A4—Anastrozole—breast cancer	0.0356	0.0699	CbGbCtD
Dutasteride—CYP3A4—Toremifene—breast cancer	0.0325	0.0639	CbGbCtD
Dutasteride—CYP3A5—Tamoxifen—breast cancer	0.0305	0.0599	CbGbCtD
Dutasteride—CYP3A4—Fulvestrant—breast cancer	0.0302	0.0594	CbGbCtD
Dutasteride—CYP3A4—Thiotepa—breast cancer	0.0269	0.053	CbGbCtD
Dutasteride—CYP3A4—Ixabepilone—breast cancer	0.0246	0.0484	CbGbCtD
Dutasteride—CYP3A4—Lapatinib—breast cancer	0.0237	0.0466	CbGbCtD
Dutasteride—CYP3A5—Paclitaxel—breast cancer	0.0237	0.0466	CbGbCtD
Dutasteride—CYP3A5—Irinotecan—breast cancer	0.0234	0.046	CbGbCtD
Dutasteride—CYP3A4—Raloxifene—breast cancer	0.018	0.0353	CbGbCtD
Dutasteride—CYP3A5—Docetaxel—breast cancer	0.0171	0.0337	CbGbCtD
Dutasteride—CYP3A4—Vinorelbine—breast cancer	0.0132	0.0259	CbGbCtD
Dutasteride—CYP3A4—Tamoxifen—breast cancer	0.0119	0.0233	CbGbCtD
Dutasteride—CYP3A4—Mitoxantrone—breast cancer	0.0116	0.0228	CbGbCtD
Dutasteride—CYP3A4—Paclitaxel—breast cancer	0.00925	0.0182	CbGbCtD
Dutasteride—CYP3A4—Irinotecan—breast cancer	0.00912	0.0179	CbGbCtD
Dutasteride—CYP3A4—Vinblastine—breast cancer	0.00811	0.0159	CbGbCtD
Dutasteride—CYP3A4—Docetaxel—breast cancer	0.00669	0.0131	CbGbCtD
Dutasteride—CYP3A4—Doxorubicin—breast cancer	0.00498	0.00979	CbGbCtD
Dutasteride—Breast pain—Anastrozole—breast cancer	0.00147	0.00941	CcSEcCtD
Dutasteride—Breast pain—Letrozole—breast cancer	0.00147	0.00941	CcSEcCtD
Dutasteride—Neoplasm malignant—Raloxifene—breast cancer	0.00142	0.00912	CcSEcCtD
Dutasteride—Tenderness—Raloxifene—breast cancer	0.00139	0.00893	CcSEcCtD
Dutasteride—Breast pain—Raloxifene—breast cancer	0.00139	0.00893	CcSEcCtD
Dutasteride—Cardiac failure—Lapatinib—breast cancer	0.00134	0.0086	CcSEcCtD
Dutasteride—Neoplasm—Exemestane—breast cancer	0.0013	0.00835	CcSEcCtD
Dutasteride—Breast enlargement—Goserelin—breast cancer	0.00129	0.00827	CcSEcCtD
Dutasteride—Cardiac failure—Toremifene—breast cancer	0.00122	0.00781	CcSEcCtD
Dutasteride—Breast cancer—Docetaxel—breast cancer	0.00117	0.00751	CcSEcCtD
Dutasteride—Neoplasm—Anastrozole—breast cancer	0.00116	0.00742	CcSEcCtD
Dutasteride—Neoplasm—Letrozole—breast cancer	0.00116	0.00742	CcSEcCtD
Dutasteride—Neoplasm malignant—Chlorambucil—breast cancer	0.00115	0.00739	CcSEcCtD
Dutasteride—Neoplasm—Idarubicin—breast cancer	0.0011	0.00704	CcSEcCtD
Dutasteride—Breast disorder—Fulvestrant—breast cancer	0.00109	0.00698	CcSEcCtD
Dutasteride—Breast disorder—Toremifene—breast cancer	0.00107	0.00689	CcSEcCtD
Dutasteride—Cardiac failure—Exemestane—breast cancer	0.00107	0.00687	CcSEcCtD
Dutasteride—Neoplasm malignant—Melphalan—breast cancer	0.001	0.00644	CcSEcCtD
Dutasteride—Tenderness—Tamoxifen—breast cancer	0.001	0.00644	CcSEcCtD
Dutasteride—Breast pain—Tamoxifen—breast cancer	0.001	0.00644	CcSEcCtD
Dutasteride—Breast pain—Goserelin—breast cancer	0.000958	0.00615	CcSEcCtD
Dutasteride—Tenderness—Goserelin—breast cancer	0.000958	0.00615	CcSEcCtD
Dutasteride—Hyperaesthesia—Vinorelbine—breast cancer	0.000954	0.00612	CcSEcCtD
Dutasteride—Cardiac failure—Letrozole—breast cancer	0.000952	0.00611	CcSEcCtD
Dutasteride—Depressed mood—Capecitabine—breast cancer	0.000925	0.00593	CcSEcCtD
Dutasteride—Neoplasm—Chlorambucil—breast cancer	0.000889	0.0057	CcSEcCtD
Dutasteride—Breast disorder—Letrozole—breast cancer	0.000839	0.00538	CcSEcCtD
Dutasteride—Neoplasm malignant—Thiotepa—breast cancer	0.000838	0.00537	CcSEcCtD
Dutasteride—Immune system disorder—Lapatinib—breast cancer	0.000818	0.00525	CcSEcCtD
Dutasteride—Neoplasm—Vinblastine—breast cancer	0.000815	0.00523	CcSEcCtD
Dutasteride—Breast disorder—Raloxifene—breast cancer	0.000797	0.00511	CcSEcCtD
Dutasteride—Mental disorder—Lapatinib—breast cancer	0.000793	0.00509	CcSEcCtD
Dutasteride—Neoplasm—Tamoxifen—breast cancer	0.000792	0.00508	CcSEcCtD
Dutasteride—Neoplasm—Melphalan—breast cancer	0.000775	0.00497	CcSEcCtD
Dutasteride—Neoplasm—Goserelin—breast cancer	0.000756	0.00485	CcSEcCtD
Dutasteride—Immune system disorder—Fulvestrant—breast cancer	0.000752	0.00482	CcSEcCtD
Dutasteride—Gynaecomastia—Goserelin—breast cancer	0.000748	0.0048	CcSEcCtD
Dutasteride—Neoplasm malignant—Irinotecan—breast cancer	0.000723	0.00464	CcSEcCtD
Dutasteride—Mental disorder—Toremifene—breast cancer	0.00072	0.00462	CcSEcCtD
Dutasteride—Neoplasm malignant—Gemcitabine—breast cancer	0.000705	0.00452	CcSEcCtD
Dutasteride—Tenderness—Gemcitabine—breast cancer	0.00069	0.00442	CcSEcCtD
Dutasteride—Tenderness—Fluorouracil—breast cancer	0.000678	0.00435	CcSEcCtD
Dutasteride—Hypersensitivity—Fluoxymesterone—breast cancer	0.000667	0.00428	CcSEcCtD
Dutasteride—Loss of libido—Methotrexate—breast cancer	0.000667	0.00428	CcSEcCtD
Dutasteride—Angioedema—Fulvestrant—breast cancer	0.000662	0.00425	CcSEcCtD
Dutasteride—Libido decreased—Goserelin—breast cancer	0.000655	0.0042	CcSEcCtD
Dutasteride—Immune system disorder—Exemestane—breast cancer	0.000653	0.00419	CcSEcCtD
Dutasteride—Hyperaesthesia—Paclitaxel—breast cancer	0.000642	0.00412	CcSEcCtD
Dutasteride—Mental disorder—Exemestane—breast cancer	0.000634	0.00406	CcSEcCtD
Dutasteride—Cardiac failure—Goserelin—breast cancer	0.000622	0.00399	CcSEcCtD
Dutasteride—Immune system disorder—Ixabepilone—breast cancer	0.000616	0.00395	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Goserelin—breast cancer	0.000602	0.00386	CcSEcCtD
Dutasteride—Mental disorder—Ixabepilone—breast cancer	0.000598	0.00384	CcSEcCtD
Dutasteride—Breast pain—Paclitaxel—breast cancer	0.000577	0.0037	CcSEcCtD
Dutasteride—Tenderness—Paclitaxel—breast cancer	0.000577	0.0037	CcSEcCtD
Dutasteride—Mental disorder—Letrozole—breast cancer	0.000563	0.00361	CcSEcCtD
Dutasteride—Neoplasm—Irinotecan—breast cancer	0.000558	0.00358	CcSEcCtD
Dutasteride—Cardiac failure—Vinorelbine—breast cancer	0.000557	0.00357	CcSEcCtD
Dutasteride—Immune system disorder—Idarubicin—breast cancer	0.000551	0.00353	CcSEcCtD
Dutasteride—Breast disorder—Goserelin—breast cancer	0.000549	0.00352	CcSEcCtD
Dutasteride—Cardiac failure—Thiotepa—breast cancer	0.000532	0.00341	CcSEcCtD
Dutasteride—Hyperaesthesia—Capecitabine—breast cancer	0.000527	0.00338	CcSEcCtD
Dutasteride—Angioedema—Letrozole—breast cancer	0.000511	0.00328	CcSEcCtD
Dutasteride—Angioedema—Anastrozole—breast cancer	0.000511	0.00328	CcSEcCtD
Dutasteride—Erectile dysfunction—Tamoxifen—breast cancer	0.000506	0.00325	CcSEcCtD
Dutasteride—Erectile dysfunction—Goserelin—breast cancer	0.000483	0.0031	CcSEcCtD
Dutasteride—Hypersensitivity—Lapatinib—breast cancer	0.000474	0.00304	CcSEcCtD
Dutasteride—Urticaria—Fulvestrant—breast cancer	0.00047	0.00301	CcSEcCtD
Dutasteride—Cardiac failure—Mitoxantrone—breast cancer	0.000459	0.00295	CcSEcCtD
Dutasteride—Neoplasm—Paclitaxel—breast cancer	0.000455	0.00292	CcSEcCtD
Dutasteride—Pruritus—Lapatinib—breast cancer	0.000455	0.00292	CcSEcCtD
Dutasteride—Cardiac failure—Gemcitabine—breast cancer	0.000448	0.00287	CcSEcCtD
Dutasteride—Cardiac failure—Fluorouracil—breast cancer	0.00044	0.00282	CcSEcCtD
Dutasteride—Hypersensitivity—Fulvestrant—breast cancer	0.000436	0.0028	CcSEcCtD
Dutasteride—Pruritus—Fulvestrant—breast cancer	0.000418	0.00268	CcSEcCtD
Dutasteride—Pruritus—Toremifene—breast cancer	0.000413	0.00265	CcSEcCtD
Dutasteride—Urticaria—Exemestane—breast cancer	0.000408	0.00262	CcSEcCtD
Dutasteride—Rash—Lapatinib—breast cancer	0.000406	0.0026	CcSEcCtD
Dutasteride—Dermatitis—Lapatinib—breast cancer	0.000405	0.0026	CcSEcCtD
Dutasteride—Angioedema—Chlorambucil—breast cancer	0.000393	0.00252	CcSEcCtD
Dutasteride—Dizziness—Fulvestrant—breast cancer	0.000391	0.00251	CcSEcCtD
Dutasteride—Immune system disorder—Melphalan—breast cancer	0.000389	0.00249	CcSEcCtD
Dutasteride—Neoplasm—Docetaxel—breast cancer	0.000386	0.00248	CcSEcCtD
Dutasteride—Dizziness—Toremifene—breast cancer	0.000386	0.00248	CcSEcCtD
Dutasteride—Immune system disorder—Goserelin—breast cancer	0.000379	0.00243	CcSEcCtD
Dutasteride—Hypersensitivity—Exemestane—breast cancer	0.000379	0.00243	CcSEcCtD
Dutasteride—Cardiac failure—Paclitaxel—breast cancer	0.000375	0.0024	CcSEcCtD
Dutasteride—Neoplasm—Capecitabine—breast cancer	0.000374	0.0024	CcSEcCtD
Dutasteride—Rash—Fulvestrant—breast cancer	0.000373	0.00239	CcSEcCtD
Dutasteride—Dermatitis—Fulvestrant—breast cancer	0.000373	0.00239	CcSEcCtD
Dutasteride—Rash—Toremifene—breast cancer	0.000368	0.00236	CcSEcCtD
Dutasteride—Mental disorder—Goserelin—breast cancer	0.000368	0.00236	CcSEcCtD
Dutasteride—Dermatitis—Toremifene—breast cancer	0.000368	0.00236	CcSEcCtD
Dutasteride—Hyperaesthesia—Epirubicin—breast cancer	0.000367	0.00235	CcSEcCtD
Dutasteride—Pruritus—Exemestane—breast cancer	0.000363	0.00233	CcSEcCtD
Dutasteride—Urticaria—Anastrozole—breast cancer	0.000363	0.00233	CcSEcCtD
Dutasteride—Urticaria—Letrozole—breast cancer	0.000363	0.00233	CcSEcCtD
Dutasteride—Hypersensitivity—Ixabepilone—breast cancer	0.000357	0.00229	CcSEcCtD
Dutasteride—Erectile dysfunction—Mitoxantrone—breast cancer	0.000357	0.00229	CcSEcCtD
Dutasteride—Angioedema—Tamoxifen—breast cancer	0.00035	0.00224	CcSEcCtD
Dutasteride—Urticaria—Idarubicin—breast cancer	0.000344	0.00221	CcSEcCtD
Dutasteride—Pruritus—Ixabepilone—breast cancer	0.000343	0.0022	CcSEcCtD
Dutasteride—Immune system disorder—Vinorelbine—breast cancer	0.00034	0.00218	CcSEcCtD
Dutasteride—Dizziness—Exemestane—breast cancer	0.00034	0.00218	CcSEcCtD
Dutasteride—Hyperaesthesia—Doxorubicin—breast cancer	0.00034	0.00218	CcSEcCtD
Dutasteride—Neoplasm malignant—Epirubicin—breast cancer	0.000337	0.00216	CcSEcCtD
Dutasteride—Hypersensitivity—Anastrozole—breast cancer	0.000336	0.00216	CcSEcCtD
Dutasteride—Breast disorder—Paclitaxel—breast cancer	0.00033	0.00212	CcSEcCtD
Dutasteride—Breast pain—Epirubicin—breast cancer	0.00033	0.00212	CcSEcCtD
Dutasteride—Immune system disorder—Thiotepa—breast cancer	0.000324	0.00208	CcSEcCtD
Dutasteride—Rash—Exemestane—breast cancer	0.000324	0.00208	CcSEcCtD
Dutasteride—Libido decreased—Capecitabine—breast cancer	0.000324	0.00208	CcSEcCtD
Dutasteride—Dermatitis—Exemestane—breast cancer	0.000324	0.00208	CcSEcCtD
Dutasteride—Pruritus—Anastrozole—breast cancer	0.000323	0.00207	CcSEcCtD
Dutasteride—Pruritus—Letrozole—breast cancer	0.000323	0.00207	CcSEcCtD
Dutasteride—Dizziness—Ixabepilone—breast cancer	0.000321	0.00206	CcSEcCtD
Dutasteride—Hypersensitivity—Idarubicin—breast cancer	0.000319	0.00205	CcSEcCtD
Dutasteride—Cardiac failure—Docetaxel—breast cancer	0.000318	0.00204	CcSEcCtD
Dutasteride—Mental disorder—Thiotepa—breast cancer	0.000315	0.00202	CcSEcCtD
Dutasteride—Neoplasm malignant—Doxorubicin—breast cancer	0.000312	0.002	CcSEcCtD
Dutasteride—Cardiac failure—Capecitabine—breast cancer	0.000308	0.00197	CcSEcCtD
Dutasteride—Rash—Ixabepilone—breast cancer	0.000306	0.00196	CcSEcCtD
Dutasteride—Breast pain—Doxorubicin—breast cancer	0.000305	0.00196	CcSEcCtD
Dutasteride—Dermatitis—Ixabepilone—breast cancer	0.000305	0.00196	CcSEcCtD
Dutasteride—Dizziness—Anastrozole—breast cancer	0.000302	0.00194	CcSEcCtD
Dutasteride—Dizziness—Letrozole—breast cancer	0.000302	0.00194	CcSEcCtD
Dutasteride—Angioedema—Vinorelbine—breast cancer	0.000299	0.00192	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Capecitabine—breast cancer	0.000298	0.00191	CcSEcCtD
Dutasteride—Rash—Anastrozole—breast cancer	0.000288	0.00185	CcSEcCtD
Dutasteride—Rash—Letrozole—breast cancer	0.000288	0.00185	CcSEcCtD
Dutasteride—Dermatitis—Letrozole—breast cancer	0.000288	0.00184	CcSEcCtD
Dutasteride—Dermatitis—Anastrozole—breast cancer	0.000288	0.00184	CcSEcCtD
Dutasteride—Dizziness—Raloxifene—breast cancer	0.000286	0.00184	CcSEcCtD
Dutasteride—Immune system disorder—Irinotecan—breast cancer	0.00028	0.0018	CcSEcCtD
Dutasteride—Breast disorder—Docetaxel—breast cancer	0.00028	0.0018	CcSEcCtD
Dutasteride—Urticaria—Chlorambucil—breast cancer	0.000279	0.00179	CcSEcCtD
Dutasteride—Neoplasm—Methotrexate—breast cancer	0.000278	0.00179	CcSEcCtD
Dutasteride—Gynaecomastia—Methotrexate—breast cancer	0.000275	0.00177	CcSEcCtD
Dutasteride—Rash—Idarubicin—breast cancer	0.000273	0.00175	CcSEcCtD
Dutasteride—Rash—Raloxifene—breast cancer	0.000273	0.00175	CcSEcCtD
Dutasteride—Immune system disorder—Gemcitabine—breast cancer	0.000273	0.00175	CcSEcCtD
Dutasteride—Dermatitis—Raloxifene—breast cancer	0.000273	0.00175	CcSEcCtD
Dutasteride—Dermatitis—Idarubicin—breast cancer	0.000273	0.00175	CcSEcCtD
Dutasteride—Breast disorder—Capecitabine—breast cancer	0.000271	0.00174	CcSEcCtD
Dutasteride—Neoplasm—Epirubicin—breast cancer	0.00026	0.00167	CcSEcCtD
Dutasteride—Hypersensitivity—Chlorambucil—breast cancer	0.000259	0.00166	CcSEcCtD
Dutasteride—Pruritus—Chlorambucil—breast cancer	0.000248	0.00159	CcSEcCtD
Dutasteride—Urticaria—Tamoxifen—breast cancer	0.000248	0.00159	CcSEcCtD
Dutasteride—Urticaria—Melphalan—breast cancer	0.000243	0.00156	CcSEcCtD
Dutasteride—Neoplasm—Doxorubicin—breast cancer	0.000241	0.00155	CcSEcCtD
Dutasteride—Urticaria—Goserelin—breast cancer	0.000237	0.00152	CcSEcCtD
Dutasteride—Hypersensitivity—Vinblastine—breast cancer	0.000237	0.00152	CcSEcCtD
Dutasteride—Hypersensitivity—Tamoxifen—breast cancer	0.00023	0.00148	CcSEcCtD
Dutasteride—Immune system disorder—Paclitaxel—breast cancer	0.000229	0.00147	CcSEcCtD
Dutasteride—Hypersensitivity—Melphalan—breast cancer	0.000225	0.00145	CcSEcCtD
Dutasteride—Mental disorder—Paclitaxel—breast cancer	0.000222	0.00142	CcSEcCtD
Dutasteride—Pruritus—Tamoxifen—breast cancer	0.000221	0.00142	CcSEcCtD
Dutasteride—Hypersensitivity—Goserelin—breast cancer	0.00022	0.00141	CcSEcCtD
Dutasteride—Pruritus—Melphalan—breast cancer	0.000216	0.00139	CcSEcCtD
Dutasteride—Cardiac failure—Epirubicin—breast cancer	0.000214	0.00137	CcSEcCtD
Dutasteride—Dizziness—Vinblastine—breast cancer	0.000213	0.00136	CcSEcCtD
Dutasteride—Urticaria—Vinorelbine—breast cancer	0.000212	0.00136	CcSEcCtD
Dutasteride—Pruritus—Goserelin—breast cancer	0.000211	0.00135	CcSEcCtD
Dutasteride—Dizziness—Tamoxifen—breast cancer	0.000207	0.00133	CcSEcCtD
Dutasteride—Urticaria—Thiotepa—breast cancer	0.000203	0.0013	CcSEcCtD
Dutasteride—Breast disorder—Methotrexate—breast cancer	0.000202	0.0013	CcSEcCtD
Dutasteride—Angioedema—Paclitaxel—breast cancer	0.000201	0.00129	CcSEcCtD
Dutasteride—Cardiac failure—Doxorubicin—breast cancer	0.000198	0.00127	CcSEcCtD
Dutasteride—Dizziness—Goserelin—breast cancer	0.000197	0.00127	CcSEcCtD
Dutasteride—Rash—Tamoxifen—breast cancer	0.000197	0.00126	CcSEcCtD
Dutasteride—Hypersensitivity—Vinorelbine—breast cancer	0.000197	0.00126	CcSEcCtD
Dutasteride—Dermatitis—Tamoxifen—breast cancer	0.000197	0.00126	CcSEcCtD
Dutasteride—Immune system disorder—Docetaxel—breast cancer	0.000194	0.00124	CcSEcCtD
Dutasteride—Rash—Melphalan—breast cancer	0.000193	0.00124	CcSEcCtD
Dutasteride—Dermatitis—Melphalan—breast cancer	0.000193	0.00124	CcSEcCtD
Dutasteride—Pruritus—Vinorelbine—breast cancer	0.000189	0.00121	CcSEcCtD
Dutasteride—Breast disorder—Epirubicin—breast cancer	0.000189	0.00121	CcSEcCtD
Dutasteride—Rash—Goserelin—breast cancer	0.000188	0.00121	CcSEcCtD
Dutasteride—Hypersensitivity—Thiotepa—breast cancer	0.000188	0.00121	CcSEcCtD
Dutasteride—Dermatitis—Goserelin—breast cancer	0.000188	0.00121	CcSEcCtD
Dutasteride—Mental disorder—Docetaxel—breast cancer	0.000188	0.00121	CcSEcCtD
Dutasteride—Immune system disorder—Capecitabine—breast cancer	0.000188	0.0012	CcSEcCtD
Dutasteride—Mental disorder—Capecitabine—breast cancer	0.000182	0.00117	CcSEcCtD
Dutasteride—Pruritus—Thiotepa—breast cancer	0.000181	0.00116	CcSEcCtD
Dutasteride—Erectile dysfunction—Methotrexate—breast cancer	0.000178	0.00114	CcSEcCtD
Dutasteride—Dizziness—Vinorelbine—breast cancer	0.000177	0.00113	CcSEcCtD
Dutasteride—Urticaria—Mitoxantrone—breast cancer	0.000175	0.00112	CcSEcCtD
Dutasteride—Breast disorder—Doxorubicin—breast cancer	0.000175	0.00112	CcSEcCtD
Dutasteride—Dizziness—Thiotepa—breast cancer	0.000169	0.00108	CcSEcCtD
Dutasteride—Rash—Vinorelbine—breast cancer	0.000168	0.00108	CcSEcCtD
Dutasteride—Dermatitis—Vinorelbine—breast cancer	0.000168	0.00108	CcSEcCtD
Dutasteride—Urticaria—Fluorouracil—breast cancer	0.000168	0.00108	CcSEcCtD
Dutasteride—Hypersensitivity—Mitoxantrone—breast cancer	0.000162	0.00104	CcSEcCtD
Dutasteride—Hypersensitivity—Irinotecan—breast cancer	0.000162	0.00104	CcSEcCtD
Dutasteride—Rash—Thiotepa—breast cancer	0.000161	0.00103	CcSEcCtD
Dutasteride—Dermatitis—Thiotepa—breast cancer	0.000161	0.00103	CcSEcCtD
Dutasteride—Hypersensitivity—Fluorouracil—breast cancer	0.000156	0.000998	CcSEcCtD
Dutasteride—Pruritus—Gemcitabine—breast cancer	0.000152	0.000974	CcSEcCtD
Dutasteride—Pruritus—Fluorouracil—breast cancer	0.000149	0.000958	CcSEcCtD
Dutasteride—Dizziness—Irinotecan—breast cancer	0.000146	0.000935	CcSEcCtD
Dutasteride—Urticaria—Paclitaxel—breast cancer	0.000143	0.000916	CcSEcCtD
Dutasteride—Immune system disorder—Methotrexate—breast cancer	0.00014	0.000896	CcSEcCtD
Dutasteride—Dizziness—Fluorouracil—breast cancer	0.00014	0.000895	CcSEcCtD
Dutasteride—Rash—Irinotecan—breast cancer	0.000139	0.000891	CcSEcCtD
Dutasteride—Rash—Mitoxantrone—breast cancer	0.000139	0.000891	CcSEcCtD
Dutasteride—Dermatitis—Mitoxantrone—breast cancer	0.000139	0.000891	CcSEcCtD
Dutasteride—Dermatitis—Irinotecan—breast cancer	0.000139	0.000891	CcSEcCtD
Dutasteride—Mental disorder—Methotrexate—breast cancer	0.000135	0.000869	CcSEcCtD
Dutasteride—Rash—Gemcitabine—breast cancer	0.000135	0.000868	CcSEcCtD
Dutasteride—Dermatitis—Gemcitabine—breast cancer	0.000135	0.000868	CcSEcCtD
Dutasteride—Rash—Fluorouracil—breast cancer	0.000133	0.000854	CcSEcCtD
Dutasteride—Dermatitis—Fluorouracil—breast cancer	0.000133	0.000853	CcSEcCtD
Dutasteride—Hypersensitivity—Paclitaxel—breast cancer	0.000132	0.00085	CcSEcCtD
Dutasteride—Immune system disorder—Epirubicin—breast cancer	0.000131	0.000838	CcSEcCtD
Dutasteride—Pruritus—Paclitaxel—breast cancer	0.000127	0.000816	CcSEcCtD
Dutasteride—Mental disorder—Epirubicin—breast cancer	0.000127	0.000813	CcSEcCtD
Dutasteride—Immune system disorder—Doxorubicin—breast cancer	0.000121	0.000775	CcSEcCtD
Dutasteride—Dizziness—Paclitaxel—breast cancer	0.000119	0.000763	CcSEcCtD
Dutasteride—Mental disorder—Doxorubicin—breast cancer	0.000117	0.000752	CcSEcCtD
Dutasteride—Urticaria—Capecitabine—breast cancer	0.000117	0.000752	CcSEcCtD
Dutasteride—Rash—Paclitaxel—breast cancer	0.000113	0.000727	CcSEcCtD
Dutasteride—Dermatitis—Paclitaxel—breast cancer	0.000113	0.000726	CcSEcCtD
Dutasteride—Hypersensitivity—Docetaxel—breast cancer	0.000112	0.00072	CcSEcCtD
Dutasteride—Hypersensitivity—Capecitabine—breast cancer	0.000109	0.000697	CcSEcCtD
Dutasteride—Pruritus—Docetaxel—breast cancer	0.000108	0.000691	CcSEcCtD
Dutasteride—Pruritus—Capecitabine—breast cancer	0.000104	0.000669	CcSEcCtD
Dutasteride—Dizziness—Docetaxel—breast cancer	0.000101	0.000646	CcSEcCtD
Dutasteride—Dizziness—Capecitabine—breast cancer	9.75e-05	0.000626	CcSEcCtD
Dutasteride—Rash—Docetaxel—breast cancer	9.61e-05	0.000616	CcSEcCtD
Dutasteride—Dermatitis—Docetaxel—breast cancer	9.6e-05	0.000616	CcSEcCtD
Dutasteride—Rash—Capecitabine—breast cancer	9.3e-05	0.000597	CcSEcCtD
Dutasteride—Dermatitis—Capecitabine—breast cancer	9.29e-05	0.000596	CcSEcCtD
Dutasteride—Urticaria—Methotrexate—breast cancer	8.72e-05	0.00056	CcSEcCtD
Dutasteride—Urticaria—Epirubicin—breast cancer	8.16e-05	0.000524	CcSEcCtD
Dutasteride—Hypersensitivity—Methotrexate—breast cancer	8.09e-05	0.000519	CcSEcCtD
Dutasteride—Pruritus—Methotrexate—breast cancer	7.77e-05	0.000498	CcSEcCtD
Dutasteride—Hypersensitivity—Epirubicin—breast cancer	7.57e-05	0.000486	CcSEcCtD
Dutasteride—Urticaria—Doxorubicin—breast cancer	7.55e-05	0.000485	CcSEcCtD
Dutasteride—Pruritus—Epirubicin—breast cancer	7.27e-05	0.000466	CcSEcCtD
Dutasteride—Dizziness—Methotrexate—breast cancer	7.26e-05	0.000466	CcSEcCtD
Dutasteride—Hypersensitivity—Doxorubicin—breast cancer	7.01e-05	0.000449	CcSEcCtD
Dutasteride—Rash—Methotrexate—breast cancer	6.92e-05	0.000444	CcSEcCtD
Dutasteride—Dermatitis—Methotrexate—breast cancer	6.92e-05	0.000444	CcSEcCtD
Dutasteride—Dizziness—Epirubicin—breast cancer	6.8e-05	0.000436	CcSEcCtD
Dutasteride—Pruritus—Doxorubicin—breast cancer	6.73e-05	0.000432	CcSEcCtD
Dutasteride—Rash—Epirubicin—breast cancer	6.48e-05	0.000416	CcSEcCtD
Dutasteride—Dermatitis—Epirubicin—breast cancer	6.47e-05	0.000415	CcSEcCtD
Dutasteride—Dizziness—Doxorubicin—breast cancer	6.29e-05	0.000403	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—ERCC2—breast cancer	6.22e-05	0.000702	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ERCC2—breast cancer	6.22e-05	0.000702	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP19A1—breast cancer	6.21e-05	0.0007	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP19A1—breast cancer	6.12e-05	0.00069	CbGpPWpGaD
Dutasteride—Rash—Doxorubicin—breast cancer	5.99e-05	0.000385	CcSEcCtD
Dutasteride—Dermatitis—Doxorubicin—breast cancer	5.99e-05	0.000384	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—MTHFR—breast cancer	5.85e-05	0.00066	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—MTHFR—breast cancer	5.85e-05	0.00066	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTA3—breast cancer	5.84e-05	0.000659	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	5.78e-05	0.000651	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—COMT—breast cancer	5.77e-05	0.000651	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	5.76e-05	0.00065	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTP1—breast cancer	5.74e-05	0.000648	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—COMT—breast cancer	5.69e-05	0.000642	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTP1—breast cancer	5.66e-05	0.000639	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	5.51e-05	0.000621	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	5.43e-05	0.000612	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	5.4e-05	0.000609	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CAV1—breast cancer	5.4e-05	0.000609	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CAV1—breast cancer	5.4e-05	0.000609	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTA4—breast cancer	5.34e-05	0.000602	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	5.33e-05	0.000601	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTM1—breast cancer	5.28e-05	0.000595	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	5.27e-05	0.000594	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTA2—breast cancer	5.21e-05	0.000587	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTM1—breast cancer	5.2e-05	0.000587	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.16e-05	0.000581	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.16e-05	0.000581	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—SULT1A1—breast cancer	5.14e-05	0.00058	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	5.13e-05	0.000579	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	5.07e-05	0.000572	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	5.07e-05	0.000572	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTA1—breast cancer	5.02e-05	0.000566	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP1A1—breast cancer	5e-05	0.000564	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—NAT2—breast cancer	4.97e-05	0.00056	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP1A1—breast cancer	4.93e-05	0.000556	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CG—breast cancer	4.92e-05	0.000554	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CG—breast cancer	4.92e-05	0.000554	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	4.9e-05	0.000552	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	4.38e-05	0.000494	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CD—breast cancer	4.32e-05	0.000487	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CD—breast cancer	4.32e-05	0.000487	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ALB—breast cancer	4.27e-05	0.000481	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALB—breast cancer	4.27e-05	0.000481	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	4.12e-05	0.000465	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NOS3—breast cancer	4.08e-05	0.00046	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NOS3—breast cancer	4.08e-05	0.00046	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—MTR—breast cancer	4.05e-05	0.000457	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SYNJ2—breast cancer	4.02e-05	0.000454	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.97e-05	0.000448	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTT1—breast cancer	3.85e-05	0.000434	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CB—breast cancer	3.77e-05	0.000425	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CB—breast cancer	3.77e-05	0.000425	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NDUFS3—breast cancer	3.74e-05	0.000422	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTGS2—breast cancer	3.73e-05	0.000421	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTGS2—breast cancer	3.73e-05	0.000421	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP17A1—breast cancer	3.65e-05	0.000411	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—PTGS1—breast cancer	3.61e-05	0.000407	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	3.6e-05	0.000405	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP2D6—breast cancer	3.54e-05	0.000399	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CHST9—breast cancer	3.52e-05	0.000397	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	3.49e-05	0.000394	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—NCOA2—breast cancer	3.47e-05	0.000392	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—COX11—breast cancer	3.33e-05	0.000376	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTEN—breast cancer	3.25e-05	0.000367	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTEN—breast cancer	3.25e-05	0.000367	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP1B1—breast cancer	3.07e-05	0.000346	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CDA—breast cancer	3.05e-05	0.000344	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SHMT1—breast cancer	3.05e-05	0.000344	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	3.03e-05	0.000341	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC2A5—breast cancer	2.94e-05	0.000331	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLCO1B1—breast cancer	2.94e-05	0.000331	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.93e-05	0.00033	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.88e-05	0.000325	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.85e-05	0.000321	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—APRT—breast cancer	2.84e-05	0.00032	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—COMT—breast cancer	2.68e-05	0.000302	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.67e-05	0.000301	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ESRRA—breast cancer	2.67e-05	0.000301	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ANGPTL4—breast cancer	2.67e-05	0.000301	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.65e-05	0.000298	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.63e-05	0.000297	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPI—breast cancer	2.53e-05	0.000285	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HADHB—breast cancer	2.53e-05	0.000285	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.45e-05	0.000277	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.42e-05	0.000273	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALDH1A1—breast cancer	2.41e-05	0.000272	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALDH7A1—breast cancer	2.41e-05	0.000272	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.33e-05	0.000262	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ADSL—breast cancer	2.31e-05	0.000261	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PHGDH—breast cancer	2.31e-05	0.000261	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—UMPS—breast cancer	2.31e-05	0.000261	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—FHL2—breast cancer	2.31e-05	0.000261	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NME1—breast cancer	2.31e-05	0.000261	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CA—breast cancer	2.3e-05	0.000259	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CA—breast cancer	2.3e-05	0.000259	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.29e-05	0.000259	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BRIP1—breast cancer	2.27e-05	0.000256	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HPSE—breast cancer	2.27e-05	0.000256	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—LDHB—breast cancer	2.27e-05	0.000256	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HMMR—breast cancer	2.15e-05	0.000242	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTA3—breast cancer	2.15e-05	0.000242	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCC1—breast cancer	2.15e-05	0.000242	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PPARGC1B—breast cancer	2.08e-05	0.000235	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CA9—breast cancer	1.97e-05	0.000222	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTA4—breast cancer	1.97e-05	0.000222	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTA2—breast cancer	1.92e-05	0.000216	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPX2—breast cancer	1.92e-05	0.000216	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SULT1A1—breast cancer	1.89e-05	0.000213	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPX4—breast cancer	1.89e-05	0.000213	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—AKT1—breast cancer	1.88e-05	0.000212	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKT1—breast cancer	1.88e-05	0.000212	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SYNJ2—breast cancer	1.87e-05	0.000211	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—IDH1—breast cancer	1.85e-05	0.000208	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTA1—breast cancer	1.85e-05	0.000208	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NAT2—breast cancer	1.83e-05	0.000206	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NDUFS3—breast cancer	1.74e-05	0.000196	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CHST9—breast cancer	1.64e-05	0.000184	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—DPYD—breast cancer	1.6e-05	0.000181	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MED12—breast cancer	1.6e-05	0.000181	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALDOA—breast cancer	1.58e-05	0.000178	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—COX11—breast cancer	1.55e-05	0.000175	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOA3—breast cancer	1.53e-05	0.000173	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC2A2—breast cancer	1.52e-05	0.000171	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCG2—breast cancer	1.49e-05	0.000168	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CPT1A—breast cancer	1.49e-05	0.000168	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MTR—breast cancer	1.49e-05	0.000168	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HPGDS—breast cancer	1.46e-05	0.000165	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HBA1—breast cancer	1.45e-05	0.000164	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SHMT1—breast cancer	1.42e-05	0.00016	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CDA—breast cancer	1.42e-05	0.00016	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ACHE—breast cancer	1.42e-05	0.00016	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTT1—breast cancer	1.42e-05	0.00016	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.36e-05	0.000154	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC2A5—breast cancer	1.36e-05	0.000154	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP17A1—breast cancer	1.34e-05	0.000151	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ENO1—breast cancer	1.33e-05	0.00015	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTGS1—breast cancer	1.33e-05	0.00015	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—APRT—breast cancer	1.32e-05	0.000149	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP2D6—breast cancer	1.3e-05	0.000147	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOA2—breast cancer	1.28e-05	0.000144	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ESRRA—breast cancer	1.24e-05	0.00014	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.24e-05	0.00014	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—FASN—breast cancer	1.24e-05	0.00014	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BCHE—breast cancer	1.23e-05	0.000139	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC5A5—breast cancer	1.22e-05	0.000137	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC2A1—breast cancer	1.18e-05	0.000133	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NQO1—breast cancer	1.18e-05	0.000133	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPI—breast cancer	1.17e-05	0.000132	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HADHB—breast cancer	1.17e-05	0.000132	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP3A4—breast cancer	1.15e-05	0.000129	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP1B1—breast cancer	1.13e-05	0.000127	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.12e-05	0.000126	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.12e-05	0.000126	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HSP90AA1—breast cancer	1.11e-05	0.000125	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOA1—breast cancer	1.08e-05	0.000121	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NME1—breast cancer	1.07e-05	0.000121	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—FHL2—breast cancer	1.07e-05	0.000121	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PHGDH—breast cancer	1.07e-05	0.000121	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ADSL—breast cancer	1.07e-05	0.000121	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—UMPS—breast cancer	1.07e-05	0.000121	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP19A1—breast cancer	1.06e-05	0.00012	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—STK11—breast cancer	1.06e-05	0.00012	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—LDHB—breast cancer	1.05e-05	0.000119	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BRIP1—breast cancer	1.05e-05	0.000119	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HPSE—breast cancer	1.05e-05	0.000119	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HMMR—breast cancer	9.99e-06	0.000113	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTA3—breast cancer	9.99e-06	0.000113	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCC1—breast cancer	9.99e-06	0.000113	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—COMT—breast cancer	9.87e-06	0.000111	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTP1—breast cancer	9.82e-06	0.000111	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HMOX1—breast cancer	9.68e-06	0.000109	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PPARGC1B—breast cancer	9.67e-06	0.000109	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ITPR1—breast cancer	9.66e-06	0.000109	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCB1—breast cancer	9.29e-06	0.000105	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTA4—breast cancer	9.14e-06	0.000103	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CA9—breast cancer	9.14e-06	0.000103	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TYMS—breast cancer	9.13e-06	0.000103	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PLA2G4A—breast cancer	9.02e-06	0.000102	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOR1—breast cancer	9.02e-06	0.000102	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTM1—breast cancer	9.02e-06	0.000102	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTA2—breast cancer	8.9e-06	0.0001	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPX2—breast cancer	8.9e-06	0.0001	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SULT1A1—breast cancer	8.79e-06	9.92e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPX4—breast cancer	8.79e-06	9.92e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPX1—breast cancer	8.64e-06	9.74e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—IDH1—breast cancer	8.59e-06	9.69e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTA1—breast cancer	8.59e-06	9.69e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP1A1—breast cancer	8.55e-06	9.65e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NAT2—breast cancer	8.49e-06	9.58e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ERCC2—breast cancer	8.48e-06	9.57e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—MTHFR—breast cancer	7.97e-06	8.99e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—DPYD—breast cancer	7.45e-06	8.4e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MED12—breast cancer	7.45e-06	8.4e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CAV1—breast cancer	7.36e-06	8.3e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALDOA—breast cancer	7.33e-06	8.27e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOA3—breast cancer	7.12e-06	8.03e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC2A2—breast cancer	7.07e-06	7.97e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCG2—breast cancer	6.92e-06	7.81e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CPT1A—breast cancer	6.92e-06	7.81e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MTR—breast cancer	6.92e-06	7.81e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HPGDS—breast cancer	6.79e-06	7.66e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HBA1—breast cancer	6.75e-06	7.61e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CG—breast cancer	6.7e-06	7.56e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTT1—breast cancer	6.59e-06	7.43e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ACHE—breast cancer	6.59e-06	7.43e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP17A1—breast cancer	6.23e-06	7.03e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTGS1—breast cancer	6.17e-06	6.96e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ENO1—breast cancer	6.17e-06	6.96e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP2D6—breast cancer	6.05e-06	6.83e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOA2—breast cancer	5.94e-06	6.7e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CD—breast cancer	5.89e-06	6.64e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALB—breast cancer	5.81e-06	6.56e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—FASN—breast cancer	5.76e-06	6.5e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BCHE—breast cancer	5.74e-06	6.47e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC5A5—breast cancer	5.67e-06	6.39e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NOS3—breast cancer	5.56e-06	6.27e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC2A1—breast cancer	5.47e-06	6.17e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NQO1—breast cancer	5.47e-06	6.17e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP1B1—breast cancer	5.25e-06	5.92e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.15e-06	5.8e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CB—breast cancer	5.13e-06	5.79e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTGS2—breast cancer	5.09e-06	5.74e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOA1—breast cancer	5.01e-06	5.65e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—STK11—breast cancer	4.93e-06	5.56e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP19A1—breast cancer	4.93e-06	5.56e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—COMT—breast cancer	4.59e-06	5.17e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTP1—breast cancer	4.57e-06	5.15e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HMOX1—breast cancer	4.5e-06	5.08e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ITPR1—breast cancer	4.49e-06	5.07e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTEN—breast cancer	4.44e-06	5e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCB1—breast cancer	4.32e-06	4.87e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TYMS—breast cancer	4.24e-06	4.79e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.2e-06	4.73e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOR1—breast cancer	4.2e-06	4.73e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTM1—breast cancer	4.2e-06	4.73e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPX1—breast cancer	4.02e-06	4.53e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP1A1—breast cancer	3.98e-06	4.48e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ERCC2—breast cancer	3.94e-06	4.45e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—MTHFR—breast cancer	3.71e-06	4.18e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CAV1—breast cancer	3.42e-06	3.86e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CA—breast cancer	3.13e-06	3.53e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CG—breast cancer	3.11e-06	3.51e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CD—breast cancer	2.74e-06	3.09e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALB—breast cancer	2.7e-06	3.05e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NOS3—breast cancer	2.59e-06	2.92e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKT1—breast cancer	2.56e-06	2.88e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CB—breast cancer	2.39e-06	2.69e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTGS2—breast cancer	2.36e-06	2.67e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTEN—breast cancer	2.06e-06	2.33e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CA—breast cancer	1.46e-06	1.64e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKT1—breast cancer	1.19e-06	1.34e-05	CbGpPWpGaD
